Separate and combined effects of empagliflozin and semaglutide on vascular function: A 32‐week randomized trial
AIM: Despite the increasing use of combination treatment with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists, data are limited on the effects of combination treatment on markers of cardiovascular disease. This study aimed to investigate the effect of empaglif...
I tiakina i:
| Ngā kaituhi matua: | , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Ingarihi |
| I whakaputaina: |
2024
|
| Urunga tuihono: | https://doi.org/10.1111/dom.15464 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.15464 |
| Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|